Advertisement

Introduction

  • Michelangelo BartoloEmail author
Chapter

Abstract

The increase in the incidence of brain tumours and the modestly improved survival due to multimodal treatment result in increasing numbers of brain tumour patients living longer with residual neurological deficits that significantly impact on quality of life. As cancer is viewed as a chronic disease, rehabilitation becomes a highly relevant aspect of care because of high rate of associated disabilities. In this regard, rehabilitative treatments performed with a multidisciplinary approach within a holistic biopsychosocial model of care may offer significant benefit to neuro-oncological patients.

References

  1. 1.
    Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008–2030): a population-based study. Lancet Oncol. 2012;13(8):790–801.CrossRefGoogle Scholar
  2. 2.
    Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.CrossRefGoogle Scholar
  3. 3.
    De Santis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64(4):252–71.CrossRefGoogle Scholar
  4. 4.
    Kirshblum S, O’Dell MW, Ho C, Barr K. Rehabilitation of persons with central nervous system tumors. Cancer. 2001;92:1029–38.CrossRefGoogle Scholar
  5. 5.
    Rose JH, Kypriotakis G, Bowman KF, Einstadter D, O’Toole EE, Mechekano R, et al. Patterns of adaptation in patients living long term with advanced care. Cancer. 2009;115(18):4298–310.CrossRefGoogle Scholar
  6. 6.
    Thorne SE, Oliffe JL, Oglov V, Gelmon K. Communication challenges for chronic metastatic cancer in an era of novel therapeutics. Qual Health Res. 2013;23(7):863–75.CrossRefGoogle Scholar
  7. 7.
    Vargo M. Brain tumor rehabilitation. Am J Phys Med Rehabil. 2011;90(Suppl):S50–62.CrossRefGoogle Scholar
  8. 8.
    Asher A, Fu JB, Bailey C, Hughes JK. Fatigue among patients with brain tumors. CNS Oncol. 2016;5(2):91–100.CrossRefGoogle Scholar
  9. 9.
    Mukand JA, Blackinton DD, Crincoli MG, Lee JJ, Santos BB. Incidence of neurologic deficits and rehabilitation of patients with brain tumors. Am J Phys Med Rehabil. 2001;80(5):346–50.CrossRefGoogle Scholar
  10. 10.
    Osoba D, Aaronson NK, Muller M, Sneeuw K, Hsu MA, Yung WK, et al. Effect of neurological dysfunction on health-related quality of life in patients with high-grade glioma. J Neurooncol. 1997;34(3):263–78.CrossRefGoogle Scholar
  11. 11.
    Giordana MT, Clara E. Functional rehabilitation and brain tumour patients. A review of outcome. Neurol Sci. 2006;27:240–4.CrossRefGoogle Scholar
  12. 12.
    Posti JP, Bori M, Kauko T, Sankinen M, Nordberg J, Rahi M, et al. Presenting symptoms of glioma in adults. Acta Neurol Scand. 2015;131(2):88–93.CrossRefGoogle Scholar
  13. 13.
    Lezak MD, Howieson DB, Bigler ED, Tranel D. Neuropsychological assessment. 5th ed. Oxford: Oxford University Press; 2012.Google Scholar
  14. 14.
    Bartolo M, Zucchella C, Pace A, Lanzetta G, Vecchione C, Bartolo M, et al. Early rehabilitation after surgery improves functional outcome in inpatients with brain tumours. J Neurooncol. 2012;107(3):537–44.CrossRefGoogle Scholar
  15. 15.
    Mauer ME, Bottomley A, Taphoorn MJ. Evaluating health-related quality of life and symptom burden in brain tumour patients: instruments for use in experimental trials and clinical practice. Curr Opin Neurol. 2008;21(6):745–53.CrossRefGoogle Scholar
  16. 16.
    Meyers CA, Hess KR, Yung WK, Levin VA. Cognitive function as a predictor of survival in patients with recurrent malignant glioma. J Clin Oncol. 2000;18(3):646–50.CrossRefGoogle Scholar
  17. 17.
    World Health Organization. International classification of functioning, disability, and health (ICF). Geneva: WHO; 2001.Google Scholar
  18. 18.
    Bickenbach J, Rubinelli S, Stucki G. Being a person with disabilities or experiencing disability: two perspectives on the social response to disability. J Rehabil Med. 2017;49(7):543–9.CrossRefGoogle Scholar
  19. 19.
    Zucchella C, Capone A, Codella V, De Nunzio AM, Vecchione C, Sandrini G, et al. Cognitive rehabilitation for early post-surgery inpatients affected by primary brain tumor: a randomized, controlled trial. J Neurooncol. 2013;114(1):93–100.CrossRefGoogle Scholar
  20. 20.
    Gehring K, Sitskoorn MM, Gundy CM, Sikkes SA, Klein M, Postma TJ, et al. Cognitive rehabilitation in patients with gliomas: a randomized controlled trial. J Clin Oncol. 2009;27(22):3712–22.CrossRefGoogle Scholar
  21. 21.
    Mustian KM, Alfano CM, Heckler C, Kleckner IR, Leach CR, Mohr D, et al. Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis. JAMA Oncol. 2017;3(7):961–8.CrossRefGoogle Scholar
  22. 22.
    Meyers FJ, Linder J. Simultaneous care: disease treatment and palliative care throughout illness. J Clin Oncol. 2003;21:1412–5.CrossRefGoogle Scholar
  23. 23.
    McCartney A, Butler C, Acreman S. Exploring access to rehabilitation services from allied health professionals for patients with primary high-grade brain tumours. Palliat Med. 2011;25(8):788–96.CrossRefGoogle Scholar
  24. 24.
    Bartolo M, Zucchella C, Pace A, De Nunzio AM, Serrao M, Sandrini G, et al. Improving neuro-oncological patients care: basic and practical concepts for nurse specialist in neuro-rehabilitation. J Exp Clin Cancer Res. 2012;31:82.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Rehabilitation, Neurorehabilitation UnitHABILITABergamoItaly

Personalised recommendations